About Otogenetics
Otogenetics is a Healthcare company based in Atlanta (United States) founded in 2007. Next-generation sequencing platforms for genetic testing are provided. The company has 21 employees. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Suite. Its legal entity is OTOGENETICS CORPORATION 401K PLAN. Its competitors include Arbor Biotechnologies, Octant and Rejuvenate Bio; 3 of its 3 listed competitors have raised funding.
Company details
Provider of the next-generation sequencing platform for genetic testing. The company offers services such as human, mouse exome sequencing, RNA sequencing, mitochondrial genome sequencing, disease panels for breast cancer genes, cardiomyopathy, colorectal cancer, etc. It also provides disease panel services (clinical) for breast cancer, deafness, inherited cancer. Also, it offers products and reagents such as DNA Library, preparation kits, whole mitochondrial DNA NGS Deep sequencing kits, and more
- Headquarters Atlanta, United States
- Employees 21
- SectorsHealthcare
- Website otogenetics.com
- Social LinkedIn X
- Legal Name Otogenetics Corporation 401K Plan
- Latest Funding Round$229.4K (USD), Grant
Sep 2009
- Investors
- Employee Count21
Funding Insights of Otogenetics
- Total Rounds 1
- Last Round Grant — $229,404
- First Round $229,404
(Sep 2009)
- Investors Count 1
All 1 funding rounds of Otogenetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2009 | $229,404 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Otogenetics
Otogenetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Otogenetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Otogenetics
13 people are tracked at Otogenetics (6 in leadership, 7 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Ping Helen Chen | Managing Director | Leadership |
Zack Cox, RN | Regional Sales Director | Leadership |
Lindsey Williams | Chief Strategy Officer | Leadership |
Larry Hung | Medical Director | Leadership |
Xi Erick Lin | Founder | Leadership |
Angela Alexander | Associate Director | Leadership |
Jeffrey Cyr | Regional Sales Manager | Team |
Bryn Martin | Clinical Sales Territory Manager | Team |
Sarah Reed | Medical Laboratory Technologist | Team |
Danielle V. | Clinical Account Executive | Team |
John Christian G. Spainhour | Bioinformatics Manager | Team |
Jim Barrett | Regional Sales Manager | Team |
Michael Wynne | Clinical Genetic / Oncology Sales Manager At Otogenetics | Team |
Complete people profiles for Otogenetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Otogenetics
2 dated milestones of Otogenetics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Otogenetics is founded.
- Funding First funding round of $229K.
Competitors of Otogenetics
Otogenetics has 3 listed competitors in our database, 3 of them funded. They include Arbor Biotechnologies, Octant and Rejuvenate Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| octant.bio | 2017 | Los Angeles, United States | $110M | 63 | Human cell interaction platform is provided for drug discovery. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. |
Detailed competitors of Otogenetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Otogenetics
The website of Otogenetics (otogenetics.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▼ 80.6% vs previous month
Websites whose visitors overlap most with Otogenetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scienceexchange.com | 86% | 2.9K | #4,037,937 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Otogenetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Otogenetics
Otogenetics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Otogenetics is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Otogenetics has 21 employees.
Provider of the next-generation sequencing platform for genetic testing. The company offers services such as human, mouse exome sequencing, RNA sequencing, mitochondrial genome sequencing, disease panels for breast cancer genes, cardiomyopathy, colorectal cancer, etc. It also provides disease panel services (clinical) for breast cancer, deafness, inherited cancer. Also, it offers products and reagents such as DNA Library, preparation kits, whole mitochondrial DNA NGS Deep sequencing kits, and more.
Otogenetics's top competitors include Arbor Biotechnologies, Rejuvenate Bio and Octant.
Otogenetics has 1 investor. Key investors include HHS.
Otogenetics operates through Otogenetics Corporation 401K Plan.